{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T17:04:16Z","timestamp":1794243856382,"version":"4.9.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Fundamental Research Funds for the Central Universities of Lanzhou University","award":["lzujbky-2022-sp08"],"award-info":[{"award-number":["lzujbky-2022-sp08"]}],"id":[{"id":"https:\/\/ror.org\/01mkqqe32","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Major Science and Technology Project of Gansu Province","award":["22ZD6FA050, 22JR9KA002"],"award-info":[{"award-number":["22ZD6FA050, 22JR9KA002"]}]},{"name":"Project of Gansu Provincial Department of Education","award":["2021jyjbgs-02"],"award-info":[{"award-number":["2021jyjbgs-02"]}]},{"name":"Project of Gansu Provincial Development and Reform Commission","award":["2022\u20132024"],"award-info":[{"award-number":["2022\u20132024"]}]},{"name":"Cuiying Scientific and Technological Innovation Program of Lanzhou University Second Hospital","award":["CY2022-QN-A19 and CY2022-QN-A11"],"award-info":[{"award-number":["CY2022-QN-A19 and CY2022-QN-A11"]}],"id":[{"id":"https:\/\/ror.org\/02erhaz63","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-07897-6","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T05:54:13Z","timestamp":1772085253000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Targeting GPA33 with CAR-macrophages: a novel immunotherapeutic approach for colorectal cancer"],"prefix":"10.1186","volume":"24","author":[{"given":"Daijun","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzhang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luxi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caihao","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9267-1412","authenticated-orcid":false,"given":"Yumin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,26]]},"reference":[{"issue":"3","key":"7897_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"7897_CR2","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S1470-2045(24)00600-4","volume":"26","author":"H Sung","year":"2024","unstructured":"Sung H, Siegel RL, Laversanne M, Jiang C, Morgan E, Zahwe M, Cao Y, Bray F, Jemal A. Colorectal cancer incidence trends in younger versus older adults: an analysis of population-based cancer registry data. Lancet Oncol. 2024;26(1):51\u201363.","journal-title":"Lancet Oncol"},{"issue":"7","key":"7897_CR3","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1001\/jama.2021.0106","volume":"325","author":"LH Biller","year":"2021","unstructured":"Biller LH, Schrag D. Diagnosis and Treatment of Metastatic Colorectal Cancer: A Review. JAMA. 2021;325(7):669\u201385.","journal-title":"JAMA"},{"key":"7897_CR4","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.pharmthera.2016.06.010","volume":"166","author":"GL Beatty","year":"2016","unstructured":"Beatty GL, O\u2019Hara M. Chimeric antigen receptor-modified T cells for the treatment of solid tumors: Defining the challenges and next steps. Pharmacol Ther. 2016;166:30\u20139.","journal-title":"Pharmacol Ther"},{"key":"7897_CR5","doi-asserted-by":"crossref","unstructured":"Wang H, Tian T, Zhang J. Tumor-associated macrophages (TAMs) in colorectal cancer (CRC): from mechanism to therapy and prognosis. Int J Mol Sci 2021, 22(16).","DOI":"10.3390\/ijms22168470"},{"issue":"1","key":"7897_CR6","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41392-025-02325-5","volume":"10","author":"J Xu","year":"2025","unstructured":"Xu J, Ding L, Mei J, Hu Y, Kong X, Dai S, Bu T, Xiao Q, Ding K. Dual roles and therapeutic targeting of tumor-associated macrophages in tumor microenvironments. Signal Transduct Target Ther. 2025;10(1):268.","journal-title":"Signal Transduct Target Ther"},{"key":"7897_CR7","doi-asserted-by":"crossref","unstructured":"Mom\u010dilovi\u0107 S, Milo\u0161evi\u0107 M, Ko\u010dovi\u0107 DM, Markovi\u0107 D, Zdravkovi\u0107 D, Vignjevi\u0107 Petrinovi\u0107 S. Macrophages at the crossroads of chronic stress and cancer. Int J Mol Sci 2025, 26(14).","DOI":"10.3390\/ijms26146838"},{"issue":"5","key":"7897_CR8","doi-asserted-by":"publisher","first-page":"189411","DOI":"10.1016\/j.bbcan.2025.189411","volume":"1880","author":"L Yang","year":"2025","unstructured":"Yang L, Shao Y, Zhang Z, Li Y, Wang F, Yu H. Metabolic insights into TAMs and the tumor immune microenvironment: Regulatory mechanisms and therapeutic interventions. Biochim Biophys Acta Rev Cancer. 2025;1880(5):189411.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"21","key":"7897_CR9","doi-asserted-by":"publisher","first-page":"e2307390","DOI":"10.1002\/smll.202307390","volume":"20","author":"Q Xiao","year":"2023","unstructured":"Xiao Q, Huang J, Wang X, Chen Z, Zhang W, Liu F, Li J, Yang Z, Zhan J, Cai Y. Supramolecular Peptide Amphiphile Nanospheres Reprogram Tumor-associated Macrophage to Reshape the Immune Microenvironment for Enhanced Breast Cancer Immunotherapy. Small. 2023;20(21):e2307390.","journal-title":"Small"},{"issue":"2","key":"7897_CR10","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1073\/pnas.94.2.469","volume":"94","author":"JK Heath","year":"1997","unstructured":"Heath JK, White SJ, Johnstone CN, Catimel B, Simpson RJ, Moritz RL, Tu GF, Ji H, Whitehead RH, Groenen LC, et al. The human A33 antigen is a transmembrane glycoprotein and a novel member of the immunoglobulin superfamily. Proc Natl Acad Sci U S A. 1997;94(2):469\u201374.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"7897_CR11","first-page":"465","volume":"9","author":"P Garinchesa","year":"1996","unstructured":"Garinchesa P, Sakamoto J, Welt S, Real F, Rettig W, Old L. Organ-specific expression of the colon cancer antigen A33, a cell surface target for antibody-based therapy. Int J Oncol. 1996;9(3):465\u201371.","journal-title":"Int J Oncol"},{"issue":"2","key":"7897_CR12","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s00428-023-03583-w","volume":"485","author":"K Malmros","year":"2023","unstructured":"Malmros K, Lindholm A, Vidarsdottir H, Jirstr\u00f6m K, Nodin B, Botling J, Mattsson JSM, Micke P, Planck M, J\u00f6nsson M, et al. Diagnostic gastrointestinal markers in primary lung cancer and pulmonary metastases. Virchows Arch. 2023;485(2):347\u201357.","journal-title":"Virchows Arch"},{"issue":"1","key":"7897_CR13","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41388-024-03200-3","volume":"44","author":"T B\u00f6rding","year":"2024","unstructured":"B\u00f6rding T, Janik T, Bischoff P, Morkel M, Sers C, Horst D. GPA33 expression in colorectal cancer can be induced by WNT inhibition and targeted by cellular therapy. Oncogene. 2024;44(1):30\u201341.","journal-title":"Oncogene"},{"issue":"1\u20132","key":"7897_CR14","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jim.2009.08.009","volume":"350","author":"T Tiller","year":"2009","unstructured":"Tiller T, Busse CE, Wardemann H. Cloning and expression of murine Ig genes from single B cells. J Immunol Methods. 2009;350(1\u20132):183\u201393.","journal-title":"J Immunol Methods"},{"issue":"3","key":"7897_CR15","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1093\/oncolo\/oyab038","volume":"27","author":"DJ Juat","year":"2022","unstructured":"Juat DJ, Hachey SJ, Billimek J, Del Rosario MP, Nelson EL, Hughes CCW, Zell JA. Adoptive T-Cell Therapy in Advanced Colorectal Cancer: A Systematic Review. Oncologist. 2022;27(3):210\u20139.","journal-title":"Oncologist"},{"issue":"7","key":"7897_CR16","doi-asserted-by":"publisher","first-page":"106723","DOI":"10.4251\/wjgo.v17.i7.106723","volume":"17","author":"M-Y Chen","year":"2025","unstructured":"Chen M-Y, Wang C, Wang Y-G, Shi M. Adoptive cell therapy in colorectal cancer: Advances in chimeric antigen receptor T cells. World J Gastrointest Oncol. 2025;17(7):106723.","journal-title":"World J Gastrointest Oncol"},{"issue":"5","key":"7897_CR17","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.apsb.2020.10.020","volume":"11","author":"H Dana","year":"2020","unstructured":"Dana H, Chalbatani GM, Jalali SA, Mirzaei HR, Grupp SA, Suarez ER, Rap\u00f4so C, Webster TJ. CAR-T cells: Early successes in blood cancer and challenges in solid tumors. Acta Pharm Sin B. 2020;11(5):1129\u201347.","journal-title":"Acta Pharm Sin B"},{"key":"7897_CR18","doi-asserted-by":"publisher","first-page":"978195","DOI":"10.3389\/fimmu.2022.978195","volume":"13","author":"B Ghazi","year":"2022","unstructured":"Ghazi B, El Ghanmi A, Kandoussi S, Ghouzlani A, Badou A. CAR T-cells for colorectal cancer immunotherapy: Ready to go? Front Immunol. 2022;13:978195.","journal-title":"Front Immunol"},{"issue":"11","key":"7897_CR19","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1001\/jamaoncol.2024.3891","volume":"10","author":"N Chen","year":"2024","unstructured":"Chen N, Pu C, Zhao L, Li W, Wang C, Zhu R, Liang T, Niu C, Huang X, Tang H, et al. Chimeric Antigen Receptor T Cells Targeting CD19 and GCC in Metastatic Colorectal Cancer: A Nonrandomized Clinical Trial. JAMA Oncol. 2024;10(11):1532\u20136.","journal-title":"JAMA Oncol"},{"issue":"8","key":"7897_CR20","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1158\/2326-6066.CIR-24-0137","volume":"13","author":"Z Feng","year":"2025","unstructured":"Feng Z, Zhang X, Peng Z, Aghamajidi A, Wu Y, Hua X. Nanobody-Directed CEA-Targeting CAR T Cells Eliminate Gastrointestinal Cancer Xenografts. Cancer Immunol Res. 2025;13(8):1160\u201371.","journal-title":"Cancer Immunol Res"},{"issue":"5","key":"7897_CR21","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/j.ymthe.2017.03.010","volume":"25","author":"C Zhang","year":"2017","unstructured":"Zhang C, Wang Z, Yang Z, Wang M, Li S, Li Y, Zhang R, Xiong Z, Wei Z, Shen J, et al. Phase I Escalating-Dose Trial of CAR-T Therapy Targeting CEA+ Metastatic Colorectal Cancers. Mol Ther. 2017;25(5):1248\u201358.","journal-title":"Mol Ther"},{"issue":"4","key":"7897_CR22","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.ccell.2020.07.005","volume":"38","author":"M Hong","year":"2020","unstructured":"Hong M, Clubb JD, Chen YY. Engineering CAR-T Cells for Next-Generation Cancer Therapy. Cancer Cell. 2020;38(4):473\u201388.","journal-title":"Cancer Cell"},{"issue":"5","key":"7897_CR23","doi-asserted-by":"publisher","first-page":"557","DOI":"10.2174\/0115748928277331231218115402","volume":"19","author":"Y Liu","year":"2024","unstructured":"Liu Y, Peng C, Ahad F, Ali Zaidi SA, Muluh TA, Fu Q. Advanced Strategies of CAR-T Cell Therapy in Solid Tumors and Hematological Malignancies. Recent Pat Anticancer Drug Discov. 2024;19(5):557\u201372.","journal-title":"Recent Pat Anticancer Drug Discov"},{"issue":"11","key":"7897_CR24","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1002\/cac2.70053","volume":"45","author":"M Wang","year":"2025","unstructured":"Wang M, Qin Z, Bian X-W, Shi Y. Harnessing chimeric antigen receptor macrophages against solid tumors. Cancer Commun (Lond). 2025;45(11):1344\u201366.","journal-title":"Cancer Commun (Lond)"},{"key":"7897_CR25","doi-asserted-by":"crossref","unstructured":"Su S, Lei A, Wang X, Lu H, Wang S, Yang Y, Li N, Zhang Y, Zhang J. Induced CAR-macrophages as a novel therapeutic cell type for cancer immune cell therapies. Cells. 2022;11(10).","DOI":"10.3390\/cells11101652"},{"issue":"4","key":"7897_CR26","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1038\/s41591-025-03495-z","volume":"31","author":"KA Reiss","year":"2025","unstructured":"Reiss KA, Angelos MG, Dees EC, Yuan Y, Ueno NT, Pohlmann PR, Johnson ML, Chao J, Shestova O, Serody JS, et al. CAR-macrophage therapy for HER2-overexpressing advanced solid tumors: a phase 1 trial. Nat Med. 2025;31(4):1171\u201382.","journal-title":"Nat Med"},{"issue":"15","key":"7897_CR27","doi-asserted-by":"publisher","first-page":"7489","DOI":"10.7150\/thno.116062","volume":"15","author":"SS Rinne","year":"2025","unstructured":"Rinne SS, Vargas DB, Vaughn BA, Katugampola S, Miller BW, Veach DR, Punzalan B, de Stanchina E, Yaeger R, Miranda IC, et al. Comparison of targeting two antigens (GPA33 versus HER2) for 225Ac-pretargeted alpha-radioimmunotherapy of colorectal cancer. Theranostics. 2025;15(15):7489\u2013500.","journal-title":"Theranostics"},{"issue":"1","key":"7897_CR28","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1158\/1535-7163.MCT-21-0353","volume":"21","author":"CS Chandler","year":"2021","unstructured":"Chandler CS, Bell MM, Chung SK, Veach DR, Fung EK, Punzalan B, Burnes Vargas D, Patel M, Xu H, Guo H-F, et al. Intraperitoneal Pretargeted Radioimmunotherapy for Colorectal Peritoneal Carcinomatosis. Mol Cancer Ther. 2021;21(1):125\u201337.","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"7897_CR29","doi-asserted-by":"publisher","first-page":"1714371","DOI":"10.1080\/19420862.2020.1714371","volume":"12","author":"P Murer","year":"2020","unstructured":"Murer P, Pl\u00fcss L, Neri D. A novel human monoclonal antibody specific to the A33 glycoprotein recognizes colorectal cancer and inhibits metastasis. MAbs. 2020;12(1):1714371.","journal-title":"MAbs"},{"issue":"3","key":"7897_CR30","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/s41571-019-0297-y","volume":"17","author":"S Rafiq","year":"2019","unstructured":"Rafiq S, Hackett CS, Brentjens RJ. Engineering strategies to overcome the current roadblocks in CAR T cell therapy. Nat Rev Clin Oncol. 2019;17(3):147\u201367.","journal-title":"Nat Rev Clin Oncol"},{"issue":"81","key":"7897_CR31","doi-asserted-by":"publisher","first-page":"eadf1426","DOI":"10.1126\/sciimmunol.adf1426","volume":"8","author":"C He","year":"2023","unstructured":"He C, Mansilla-Soto J, Khanra N, Hamieh M, Bustos V, Paquette AJ, Garcia Angus A, Shore DM, Rice WJ, Khelashvili G, et al. CD19 CAR antigen engagement mechanisms and affinity tuning. Sci Immunol. 2023;8(81):eadf1426.","journal-title":"Sci Immunol"},{"issue":"12","key":"7897_CR32","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1038\/s41551-024-01258-8","volume":"8","author":"Z Xia","year":"2024","unstructured":"Xia Z, Jin Q, Long Z, He Y, Liu F, Sun C, Liao J, Wang C, Wang C, Zheng J, et al. Targeting overexpressed antigens in glioblastoma via CAR T cells with computationally designed high-affinity protein binders. Nat Biomed Eng. 2024;8(12):1634\u201350.","journal-title":"Nat Biomed Eng"},{"issue":"1","key":"7897_CR33","doi-asserted-by":"publisher","first-page":"7196","DOI":"10.1038\/s41467-025-61427-4","volume":"16","author":"M Barisa","year":"2025","unstructured":"Barisa M, Muller HP, Zappa E, Shah R, Buhl JL, Draper B, Himsworth C, Bowers C, Munnings-Tomes S, Nicolaidou M, et al. Functional avidity of anti-B7H3 CAR-T constructs predicts antigen density thresholds for triggering effector function. Nat Commun. 2025;16(1):7196.","journal-title":"Nat Commun"},{"key":"7897_CR34","doi-asserted-by":"crossref","unstructured":"Shabaneh TB, Stevens AR, Stull SM, Shimp KR, Seaton BW, Gad EA, Jaeger-Ruckstuhl CA, Simon S, Koehne AL, Price JP et al. Systemically administered low-affinity HER2 CAR T cells mediate antitumor efficacy without toxicity. J Immunother Cancer. 2024;12(2).","DOI":"10.1136\/jitc-2023-008566"},{"key":"7897_CR35","doi-asserted-by":"publisher","first-page":"114720","DOI":"10.1016\/j.intimp.2025.114720","volume":"156","author":"C Lee","year":"2025","unstructured":"Lee C, Kwak C, Choi M, Kim A, Kim S, Rhee I. Advancing immunotherapy with innovations in CAR-M engineering for cancer treatment. Int Immunopharmacol. 2025;156:114720.","journal-title":"Int Immunopharmacol"},{"key":"7897_CR36","doi-asserted-by":"crossref","unstructured":"Morrissey MA, Williamson AP, Steinbach AM, Roberts EW, Kern N, Headley MB, Vale RD. Chimeric antigen receptors that trigger phagocytosis. Elife. 2018;7.","DOI":"10.7554\/eLife.36688"},{"key":"7897_CR37","doi-asserted-by":"crossref","unstructured":"Kim J, Bae J-S. Tumor-associated macrophages and neutrophils in tumor microenvironment. Mediators Inflamm. 2016, 2016:6058147.","DOI":"10.1155\/2016\/6058147"},{"issue":"10","key":"7897_CR38","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/s41416-019-0578-3","volume":"121","author":"W Zhang","year":"2019","unstructured":"Zhang W, Liu L, Su H, Liu Q, Shen J, Dai H, Zheng W, Lu Y, Zhang W, Bei Y, et al. Chimeric antigen receptor macrophage therapy for breast tumours mediated by targeting the tumour extracellular matrix. Br J Cancer. 2019;121(10):837\u201345.","journal-title":"Br J Cancer"},{"issue":"1","key":"7897_CR39","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/s12967-023-04061-2","volume":"21","author":"Y Huo","year":"2023","unstructured":"Huo Y, Zhang H, Sa L, Zheng W, He Y, Lyu H, Sun M, Zhang L, Shan L, Yang A, et al. M1 polarization enhances the antitumor activity of chimeric antigen receptor macrophages in solid tumors. J Transl Med. 2023;21(1):225.","journal-title":"J Transl Med"},{"issue":"1","key":"7897_CR40","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1186\/s12943-024-02184-8","volume":"23","author":"H Zheng","year":"2024","unstructured":"Zheng H, Yang X, Huang N, Yuan S, Li J, Liu X, Jiang Q, Wu S, Ju Y, Kleeff J, et al. Chimeric antigen receptor macrophages targeting c-MET(CAR-M-c-MET) inhibit pancreatic cancer progression and improve cytotoxic chemotherapeutic efficacy. Mol Cancer. 2024;23(1):270.","journal-title":"Mol Cancer"},{"key":"7897_CR41","doi-asserted-by":"crossref","unstructured":"Xue G, Zheng N, Fang J, Jin G, Li X, Dotti G, Yi Q, Lu Y. Adoptive cell therapy with tumor-specific Th9 cells induces viral mimicry to eliminate antigen-loss-variant tumor cells. Cancer Cell. 2021;39(12).","DOI":"10.1016\/j.ccell.2021.09.011"},{"key":"7897_CR42","doi-asserted-by":"publisher","first-page":"724306","DOI":"10.3389\/fphar.2021.724306","volume":"12","author":"W Li","year":"2021","unstructured":"Li W, Zhou Y, Wu Z, Shi Y, Tian E, Zhu Y, Wang T, Dou W, Meng X, Chen M, et al. Targeting Wnt Signaling in the Tumor Immune Microenvironment to Enhancing EpCAM CAR T-Cell therapy. Front Pharmacol. 2021;12:724306.","journal-title":"Front Pharmacol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-07897-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-07897-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-07897-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T08:57:48Z","timestamp":1775033868000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-07897-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,26]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7897"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-07897-6","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,26]]},"assertion":[{"value":"12 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The experiments involving human tissues were approved by the Institutional Ethics Committee of the Second Hospital of Lanzhou University (2022A-670). All participants provided written informed consent. All procedures involving human participants were conducted in accordance with the Declaration of Helsinki. All animal experiments were approved by the Ethics Committee of Lanzhou University Second Hospital (D2024-570), and were performed in accordance with the Guide for the Care and Use of Laboratory Animals (8th edition, National Research Council).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"459"}}